Stocktoria
CareDx, Inc. CDNA
Nasdaq · XNAS · stock · Services-Medical Laboratories · website · IPO 2014-07-17
CareDx, Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | -8.1% | 12.2% | -72.5% | -24.0% | -10.0% |
| Net margin | -5.6% | 15.7% | -67.9% | -23.8% | -10.3% |
| Return on assets | -5.2% | 10.7% | -40.8% | -14.1% | -5.4% |
| Return on equity | -7.0% | 13.9% | -72.8% | -17.8% | -6.6% |
| Current ratio | 2.86 | 3.94 | 4.02 | 5.10 | 5.61 |
| Revenue growth | 13.8% | 19.1% | -12.9% | 8.6% | 54.2% |
Source: SEC EDGAR filings · CIK 0001217234 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.